These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34281786)

  • 1. Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: A rapid review.
    Niznik JD; Collins BJ; Armistead LT; Larson CK; Kelley CJ; Hughes TD; Sanders KA; Carlson R; Ferreri SP
    Res Social Adm Pharm; 2022 Jun; 18(6):2913-2921. PubMed ID: 34281786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial.
    Niznik J; Ferreri SP; Armistead L; Urick B; Vest MH; Zhao L; Hughes T; McBride JM; Busby-Whitehead J
    Trials; 2022 Apr; 23(1):256. PubMed ID: 35379307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary-Care Prescribers' Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults.
    Niznik JD; Ferreri SP; Armistead LT; Kelley CJ; Schlusser C; Hughes T; Henage CB; Busby-Whitehead J; Roberts E
    Drugs Aging; 2022 Sep; 39(9):739-748. PubMed ID: 35896779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Perceptions of Opioids and Benzodiazepines and Attitudes Toward Deprescribing.
    Kelley CJ; Niznik JD; Ferreri SP; Schlusser C; Armistead LT; Hughes TD; Henage CB; Busby-Whitehead J; Roberts E
    Drugs Aging; 2023 Dec; 40(12):1113-1122. PubMed ID: 37792262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients.
    Ng BJ; Le Couteur DG; Hilmer SN
    Drugs Aging; 2018 Jun; 35(6):493-521. PubMed ID: 29705831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deprescribing of benzodiazepines and Z-drugs amongst the psychiatric patients of a tertiary care Hospital.
    Shilpa HSS; Kumar NN; Maheswari E; Virupaksha HS; Subeesh V; Saraswathy GR; Kunnavil R
    Asian J Psychiatr; 2019 Aug; 44():189-194. PubMed ID: 31408799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A realist evaluation of patients' decisions to deprescribe in the EMPOWER trial.
    Martin P; Tannenbaum C
    BMJ Open; 2017 May; 7(4):e015959. PubMed ID: 28473524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' contribution to benzodiazepine deprescribing in older outpatients: a systematic review and meta-analysis.
    Melo TAR; Bezerra CO; Fernandes BD; Rotta I; Reis WCT; Aguiar PM
    Int J Clin Pharm; 2023 Oct; 45(5):1037-1049. PubMed ID: 37713028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provider beliefs about the ideal design of an opioid deprescribing and substitution intervention for older adults.
    Margraf AM; Davoodi NM; Chen K; Shield RR; McAuliffe LM; Collins CM; Zullo AR
    Am J Health Syst Pharm; 2023 Jan; 80(2):53-60. PubMed ID: 36205419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-based pharmacists' role in deprescribing: A systematic review.
    Bužančić I; Kummer I; Držaić M; Ortner Hadžiabdić M
    Br J Clin Pharmacol; 2022 Feb; 88(2):452-463. PubMed ID: 34155673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older Adult and Primary Care Practitioner Perspectives on Using, Prescribing, and Deprescribing Opioids for Chronic Pain.
    Anderson TS; Wang BX; Lindenberg JH; Herzig SJ; Berens DM; Schonberg MA
    JAMA Netw Open; 2024 Mar; 7(3):e241342. PubMed ID: 38446478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A health-system-embedded deprescribing intervention targeting patients and providers to prevent falls in older adults (STOP-FALLS trial): study protocol for a pragmatic cluster-randomized controlled trial.
    Balderson BH; Gray SL; Fujii MM; Nakata KG; Williamson BD; Cook AJ; Wellman R; Theis MK; Lewis CC; Key D; Phelan EA
    Trials; 2023 May; 24(1):322. PubMed ID: 37170329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Care and Mental Health Prescribers, Key Clinical Leaders, and Clinical Pharmacist Specialists' Perspectives on Opioids and Benzodiazepines.
    Hawkins EJ; Lott AM; Danner AN; Malte CA; Hagedorn HJ; Berger D; Donovan LM; Sayre GG; Mariano AJ; Saxon AJ
    Pain Med; 2021 Jul; 22(7):1559-1569. PubMed ID: 33661287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.
    Keller MS; Carrascoza-Bolanos J; Breda K; Kim LY; Kennelty KA; Leang DW; Murry LT; Nuckols TK; Schnipper JL; Pevnick JM
    BMJ Open; 2023 Feb; 13(2):e066234. PubMed ID: 36813499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a Pharmacist-Managed Antidiabetic Deprescribing Program in an Integrated Health Care System.
    Hui RL; Chang CC; Niu F; Tang YK; Harano D; Deguzman L; Kao DJ; Awsare S; Draves M
    J Manag Care Spec Pharm; 2019 Aug; 25(8):927-934. PubMed ID: 31347983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist interventions to deprescribe benzodiazepines in older adults: A missed opportunity?
    Cadogan CA
    Res Social Adm Pharm; 2022 Nov; 18(11):4012-4015. PubMed ID: 35768308
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacist-Led Deprescribing of Opioids and Benzodiazepines in Older Adults: Examining Implementation and Perceptions.
    Hughes TD; Sottung E; Nowak J; Sanders KA
    Pharmacy (Basel); 2024 Jul; 12(4):. PubMed ID: 39195848
    [No Abstract]   [Full Text] [Related]  

  • 18. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
    Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
    Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Pharmacist-Initiated Deprescribing Interventions in Older People: A Narrative Review of Randomized Controlled Trials.
    Nguyen M; Beier MT; Louden DN; Spears D; Gray SL
    Sr Care Pharm; 2023 Dec; 38(12):506-523. PubMed ID: 38041222
    [No Abstract]   [Full Text] [Related]  

  • 20. Deprescribing Interventions among Community-Dwelling Older Adults: A Systematic Review of Economic Evaluations.
    Romano S; Figueira D; Teixeira I; Perelman J
    Pharmacoeconomics; 2022 Mar; 40(3):269-295. PubMed ID: 34913143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.